Lepu Medical Financials
| 300003 Stock | 11.85 0.18 1.50% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.3 B | 1.8 B |
|
|
Lepu | Select Account or Indicator |
Understanding current and past Lepu Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Lepu Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Lepu Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Lepu Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lepu Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Lepu Medical's management manipulating its earnings.
Lepu Medical Stock Summary
Lepu Medical competes with TongFu Microelectronics, Ping An, GreenTech Environmental, Central Plains, and Semiconductor Manufacturing. Lepu Medical is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100000H44 |
| Business Address | 37 Chaoqian Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.lepumedical.com |
| Phone | 86 10 8012 0666 |
You should never invest in Lepu Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Lepu Stock, because this is throwing your money away. Analyzing the key information contained in Lepu Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Lepu Medical Key Financial Ratios
Lepu Medical's financial ratios allow both analysts and investors to convert raw data from Lepu Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Lepu Medical over time and compare it to other companies across industries.| Revenue | 7.98 B | ||||
| Gross Profit | 6.49 B | ||||
| EBITDA | 1.42 B | ||||
| Net Income | 1.26 B | ||||
| Total Asset | 25.02 B |
Lepu Medical Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 15.9B | 18.2B | 20.7B | 24.5B | 25.0B | 26.3B | |
| Other Current Liab | 473.3M | 766.7M | 824.4M | 109.8M | 62.5M | 59.3M | |
| Other Liab | 237.0M | 352.9M | 473.7M | 1.1B | 1.2B | 1.3B | |
| Retained Earnings | 5.8B | 7.3B | 8.7B | 9.6B | 10.2B | 10.7B | |
| Accounts Payable | 822.3M | 821.0M | 1.4B | 1.5B | 1.0B | 542.5M | |
| Cash | 2.0B | 2.4B | 3.8B | 5.5B | 4.2B | 2.2B | |
| Other Assets | 1.5B | 2.2B | 1.7B | 2.1B | 2.5B | 2.6B | |
| Net Receivables | 2.5B | 2.1B | 1.7B | 1.9B | 1.8B | 1.4B | |
| Inventory | 1.0B | 1.4B | 1.9B | 2.3B | 2.3B | 2.4B | |
| Other Current Assets | 92.7M | 175.6M | 288.4M | 90.4M | 188.0M | 119.5M | |
| Total Liab | 7.9B | 7.6B | 8.4B | 8.1B | 7.5B | 4.2B | |
| Intangible Assets | 2.0B | 1.9B | 2.1B | 2.4B | 2.7B | 2.8B | |
| Good Will | 2.7B | 2.8B | 3.3B | 3.3B | 3.5B | 2.7B | |
| Net Tangible Assets | 2.9B | 3.3B | 5.7B | 6.8B | 7.8B | 4.3B | |
| Long Term Debt | 2.5B | 2.3B | 3.9B | 2.2B | 3.1B | 2.6B | |
| Total Current Assets | 5.6B | 6.6B | 8.1B | 10.7B | 9.3B | 7.2B | |
| Short Long Term Debt | 1.5B | 1.9B | 583.9M | 380.8M | 1.0B | 936.7M | |
| Net Debt | 2.9B | 2.0B | 1.8B | 669.3M | 602.3M | 572.2M | |
| Net Invested Capital | 11.4B | 14.1B | 15.9B | 17.8B | 20.1B | 15.9B | |
| Net Working Capital | 523.9M | 1.8B | 4.8B | 5.4B | 5.6B | 3.2B |
Lepu Medical Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 321.7M | 268.9M | 228.5M | 188.8M | 170.6M | 100.0M | |
| Total Revenue | 7.8B | 8.0B | 10.7B | 10.6B | 8.0B | 4.7B | |
| Operating Income | 2.3B | 2.2B | 2.7B | 2.9B | 1.8B | 1.3B | |
| Cost Of Revenue | 2.2B | 2.7B | 4.2B | 4.0B | 2.9B | 1.6B | |
| Income Before Tax | 2.1B | 2.2B | 2.1B | 2.6B | 1.6B | 1.2B | |
| Net Income | 1.7B | 1.8B | 1.7B | 2.2B | 1.3B | 1.0B | |
| Income Tax Expense | 219.0M | 339.5M | 326.2M | 365.7M | 420.6M | 441.6M | |
| Minority Interest | 522.2M | 664.6M | (61.1M) | (42.3M) | (34.2M) | (32.4M) | |
| Research Development | 543.9M | 736.1M | 907.9M | 957.1M | 879.4M | 562.7M | |
| Gross Profit | 5.6B | 5.4B | 6.5B | 6.6B | 5.1B | 5.0B | |
| Ebit | 1.7B | 2.2B | 2.1B | 2.6B | 3.0B | 1.8B | |
| Tax Provision | 339.5M | 326.2M | 365.7M | 365.7M | 262.1M | 305.9M | |
| Net Interest Income | (286.7M) | (239.7M) | (178.3M) | (108.7M) | (59.6M) | (62.5M) | |
| Interest Income | 44.4M | 43.2M | 57.6M | 88.0M | 115.3M | 60.6M | |
| Ebitda | 2.7B | 2.9B | 2.8B | 3.3B | 3.8B | 2.8B |
Lepu Medical Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Lepu Medical Tech. It measures of how well Lepu is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Lepu Medical brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Lepu had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Lepu Medical has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 639.2M | 598.4M | 587.0M | 635.6M | 768.7M | 807.1M | |
| Capital Expenditures | 563.1M | 600.1M | 984.4M | 905.2M | 844.7M | 467.2M | |
| Net Income | 1.7B | 1.8B | 1.7B | 2.2B | 1.3B | 1.0B | |
| Change To Inventory | (205.6M) | (422.9M) | (494.7M) | (386.7M) | (251.0M) | (263.6M) | |
| Investments | 53.5M | 17.8M | 129.2M | (1.6B) | (1.9B) | (1.8B) | |
| Change In Cash | (205.4M) | 599.6M | 1.3B | 1.6B | (1.2B) | (1.1B) | |
| Net Borrowings | 2.6B | (537.3M) | (98.9M) | (592.5M) | (533.3M) | (506.6M) | |
| Depreciation | 284.5M | 388.2M | 448.7M | 488.5M | 513.6M | 349.5M | |
| Change To Netincome | 441.2M | 339.9M | 104.9M | 678.9M | 780.8M | 819.8M | |
| End Period Cash Flow | 1.8B | 2.4B | 3.7B | 5.3B | 4.1B | 3.2B | |
| Free Cash Flow | 1.4B | 1.5B | 2.1B | 1.9B | 145.7M | 138.4M | |
| Other Non Cash Items | 362.3M | 323.8M | 301.3M | 267.9M | 260.9M | 308.2M |
Lepu Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lepu Medical's current stock value. Our valuation model uses many indicators to compare Lepu Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lepu Medical competition to find correlations between indicators driving Lepu Medical's intrinsic value. More Info.Lepu Medical Tech is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.62 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Lepu Medical Tech is roughly 1.62 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lepu Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lepu Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Lepu Medical Tech Systematic Risk
Lepu Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lepu Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Lepu Medical Tech correlated with the market. If Beta is less than 0 Lepu Medical generally moves in the opposite direction as compared to the market. If Lepu Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lepu Medical Tech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lepu Medical is generally in the same direction as the market. If Beta > 1 Lepu Medical moves generally in the same direction as, but more than the movement of the benchmark.
Lepu Medical Tech Total Assets Over Time
Lepu Medical Thematic Clasifications
Lepu Medical Tech is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Lepu Medical December 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lepu Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lepu Medical Tech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Lepu Medical Tech based on widely used predictive technical indicators. In general, we focus on analyzing Lepu Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lepu Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.3 | |||
| Information Ratio | 0.0995 | |||
| Maximum Drawdown | 32.34 | |||
| Value At Risk | (3.45) | |||
| Potential Upside | 6.27 |
Complementary Tools for Lepu Stock analysis
When running Lepu Medical's price analysis, check to measure Lepu Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lepu Medical is operating at the current time. Most of Lepu Medical's value examination focuses on studying past and present price action to predict the probability of Lepu Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lepu Medical's price. Additionally, you may evaluate how the addition of Lepu Medical to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |